Skip to content

Drug interactions

Armodafinil + Palovarotene

Severity: Moderate

Armodafinil and Palovarotene: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Armodafinil may lower palovarotene exposure by inducing CYP3A4. Reduced levels could weaken its effect on heterotopic ossification in fibrodysplasia ossificans progressiva. Labeling advises avoiding moderate and strong CYP3A inducers.

What this interaction means in plain words

Armodafinil and Palovarotene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Armodafinil belongs to Central Nervous System; Palovarotene belongs to Miscellaneous.

Evidence level: Low

Why it happens

CYP3A4 induction by armodafinil increases the metabolism of palovarotene.

What to do

Prefer a non-inducing alternative to armodafinil. If the combination is needed, monitor for reduced efficacy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Palovarotene, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Palovarotene?

MediHelp rates the interaction as moderate. Armodafinil and Palovarotene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Armodafinil may lower palovarotene exposure by inducing CYP3A4. Reduced levels could weaken its effect on heterotopic ossification in fibrodysplasia ossificans progressiva. Labeling advises avoiding moderate and strong CYP3A inducers.

How serious is the interaction between Armodafinil and Palovarotene?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing alternative to armodafinil. If the combination is needed, monitor for reduced efficacy.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in